Publication: 3648

Publication: 3648

Randomized Phase II/III Study of DA-EPOCH-R +/- Venetoclax in Previously Untreated Double Hit Lymphoma: Initial Results from Alliance A051701

DOI

URL

Google Scholar

Citation:: Blood vol 138 (Supplement 1) 523

Meeting Instance:: ASH 2021
Year:: 2021
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Preliminary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882; U10CA180820 and UG1CA232760 (ECOG-ACRIN)

Corr. Author:
Authors:: Jeremy S. Abramson Amy S. Ruppert Sharmila Giri Ann Hudson Eric Hsi Richard Little Steven Gore Anusha Vallurupalli Daniel Landsburg Brad Kahl Jonathan Friedberg Nancy L. Bartlett John P. Leonard

Networks:: LAPS-MA036, LAPS-MN026, LAPS-MO011, MD001, NY018, OR013, PA121

Study: Alliance-A051701
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords: